Sarilumab [KEVZARA]

Abbreviation
SAR
Disease(s)
Covid 19; Rheumatoid arthritis
Background
.pdf
Patent oppositions filed in
Thailand

Sarilumab is a monoclonal antibody used to treat rheumatoid arthritis. Sarilumab was also used in the treatment of patients hospitalized with coronavirus 19 infection on corticosteroids. However Sarilumab did not seem to exhibit efficacy in patients hospitalized with severe coronavirus 19 infection.

This drug is missing the following documents, can you help us by contributing something?

Oppositions

Information related to relevant oppositions from around the world.

Patent Oppositions

The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.

Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.

CountryDateWho FiledOpposition typeOpposition statusPatent typeRelated patent applicationMore info
Thailand29-04-2024Thai Network of People Living with HIV/AIDS (TNP+)Pre-GrantUnder ExaminationFormulations1201003397 (WO/2011/085158) View/Comment
Thailand19-06-2024Thai Network of People Living with HIV/AIDS (TNP+)Pre-GrantUnder ExaminationFormulations1201003397 (WO/2011/085158) View/Comment

Is something missing? Help us by contributing missing data: Contribute

↑ Back to Top